Fainting disorder mechanism figured out

March 24, 2017, Monash University
Fainting disorder mechanism figured out
Fainting caused by POTS is regulated by switching gene function off. Credit: Imgur/Twoisnoe

Monash University researchers have discovered the mechanism underlying the fainting disorder, Postural Orthostatic Tachycardia Syndrome (POTS), the condition famously affecting the former lead singer of The Wiggles.

POTS is a disorder characterised by orthostatic intolerance – having difficulty in becoming upright, particularly when standing up from a lying-down position, when a greatly reduced volume of blood returns to the heart. Symptoms can include feeling light-headed, fainting, fatigue and slurred speech. Interestingly, eighty per cent of those with the condition are women.

Greg Page AM, the "Yellow Wiggle," left the popular children's music group in late 2006 for some years after developing symptoms associated with POTS, later dubbed 'Wiggles Disease'.

Monash Central Clinical School (CCS) investigators Professor Sam El-Osta and then PhD student Abdul Waleed Khan – who joined the CCS from the Baker Heart and Diabetes Institute with the opening of the new Department of Diabetes at Monash – have revealed that the problem has an epigenetic, rather than genetic, basis.

While the gene implicated in POTS – norepinephrine transporter (NET) – was known for several decades, past research had failed to find a genetic mutation responsible for symptoms of POTS.

The CCS scientists discovered chemical marks on the NET gene responsible for repressing or turning the gene off. They delved further and found that a repressor protein called MeCP2 together with a non-coding RNA (let-7i) was critical in the .

In another exciting development, the researchers, collaborating with the Baker Institute's Professor Murray Esler, demonstrated that the NET gene could be re-activated by using the FDA approved drug Vorinostat in blood cells derived from POTS study participants.

"The rationale behind our research into POTS was to understand the regulatory mechanism to piece together some of the key molecules involved in NET gene reactivation," Professor El-Osta said.

"The drug we used in the study targets specific molecules in the cell to restore NET gene function."

POTS is a relatively rare condition but the findings may have far wider application.

"This has important therapeutic implications. We have commenced clinical epigenomics studies to assess the generality of the mechanism and therapeutic potential as it pertains to essential hypertension, panic disorder and depressive illness."

Professor El-Osta is now working with Professor Esler's team, which is recruiting patients for a much larger study to test the broader application of the compounds investigated, and others like it, that may also reactivate the NET gene.

Explore further: Poorly understood postural syndrome blights lives of young well educated women

More information: Abdul Waheed Khan et al. NET silencing by let-7i in postural tachycardia syndrome, JCI Insight (2017). DOI: 10.1172/jci.insight.90183

Related Stories

Poorly understood postural syndrome blights lives of young well educated women

June 16, 2014
A debilitating syndrome that causes an excessively rapid heartbeat on standing up, predominantly affects young well educated women, and blights their lives, because it is so poorly understood and inconsistently treated, reveals ...

Low vitamin B12 linked to postural orthostatic tachycardia

December 23, 2013
(HealthDay)—During adolescence, low vitamin B12 levels are associated with postural orthostatic tachycardia syndrome (POTS), according to a study published online Dec. 23 in Pediatrics.

Scientists uncover possible therapeutic targets for rare autism spectrum disorder

January 30, 2017
Researchers have uncovered 30 genes that could, one day, serve as therapeutic targets to reverse Rett syndrome, a rare neurological disorder that affects only girls and is a severe form of an autism spectrum disorder.

Exercise training program improves outcomes in 'Grinch Syndrome' patients

June 20, 2011
An exercise training program worked better than a commonly used beta blocker, significantly improving — even curing — patients with a debilitating heart syndrome, according to research published in Hypertension: ...

Gene ABL1 implicated in both cancer and a developmental disorder

March 14, 2017
ABL1, a human gene well-known for its association with cancer now has been linked to a developmental disorder. The study, which was carried out by a team of researchers from institutions around the world, including Baylor ...

Many chest X-rays in children are unnecessary

December 3, 2014
Researchers at Mayo Clinic found that some children are receiving chest X-rays that may be unnecessary and offer no clinical benefit to the patient, according to a study presented today at the annual meeting of the Radiological ...

Recommended for you

Identifying Crohn's disease risk factors in the Ashkenazi Jewish population

May 25, 2018
It is estimated that one in three individuals of Ashkenazi Jewish (AJ) descent carry mutations that increase their risk for certain genetic diseases. For instance, Crohn's, a highly heritable inflammatory bowel disease, is ...

How do insects survive on a sugary diet?

May 25, 2018
There's a reason parents tell their kids to lay off the sugar: too much isn't good for you.

Regulatory mutations missed in standard genetic screening lead to congenital diseases

May 25, 2018
Researchers have identified a type of genetic aberration to be the cause of certain neurodevelopmental disorders and congenital diseases, such as autism and congenital heart disease, which are undetectable by conventional ...

Genome study presents new way to track historical demographics of US populations

May 24, 2018
Sharon Browning of the University of Washington and colleagues developed a method to estimate historical effective population size, which is the number of individuals who pass on their genes to the next generation, to reveal ...

New findings on autism-related disorder

May 24, 2018
In a study published today in Nature, Marc Bühler and his group at the Friedrich Miescher Institute for Biomedical Research (FMI) have taken a major step forward in elucidating the mechanisms underlying a disorder known ...

Fruit flies: 'Living test tubes' to rapidly screen potential disease-causing human gene

May 22, 2018
It all began with one young patient; a 7-year old boy who was born without a thymus, an important organ of the immune system, and without functional immune cells. The boy also presented with cardiac and skeletal defects, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.